Cocoa Powder (antioxidant boost)
According to the recently reported results of a phase 2 trial in patients with gastrointestinal stromal tumors, linsitinib achieved no objective responses in these patients, although the rate of 9-month clinical benefit, progression-free survival, and overall survival at 9 months was 40%, 52% and 80%, respectively [162]
"Why would this matter
July 2024: A study published in JAMA Ophthalmology suggests that Ozempic users could be at higher risk of NAION, a condition that can cause sudden and permanent vision loss
From insulin resistance, chronic inflammation, cardiovascular disease, and MASLD to cancer, BCAA metabolic dysregulation participates in the pathogenesis and progression of various metabolic diseases
Are there safer, cheaper, natural alternatives to boost GLP-1 with diet and lifestyle? In this primer, Dr